Construction and validation of a risk prediction model for hyperamylasemia after kidney transplantation
BackgroundKidney transplantation (KT) is the preferred treatment for patients with end-stage renal disease (ESRD); however, postoperative hyperamylasemia (HA) remains common and has been associated with acute rejection (AR), infection, and impaired gra…